Immunoassays for anti-HCV antibodies employing combinations of hepatitis C virus (HCV) antigens
US5712087A · kind A · utility
44Cited by
6References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 12, 1995 |
| Grant date | Jan 27, 1998 |
| Priority date | — |
| Expiry date | May 12, 2015 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S436/82
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
Combinations of HCV antigens that have a broader range of immunological reactivity than any single HCV antigen. The combinations consist of an antigen from the C domain of the HCV polyprotein, and at least one additional HCV antigen from either the NS3 domain, the NS4 domain, the S domain, or the NS5 domain, and are in the form of a fusion protein, a simple physical mixture, or the individual antigens commonly bound to a solid matrix.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.